semaglutide training for nurse practitioners Accredited Wegovy and Mounjaro Training

Which one stands out, and whats the verdict on the frequently debated question: tirzepatide vs

Just to add DCGI has approved for overweight pt with atleast 1 weight related comorbidity

Semaglutide is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), history of pancreatitis, pregnancy or breastfeeding, and severe gastrointestinal disorders such as gastroparesis

No clinic visit, no appointment needed

Wegovy and Zepbound require a $99 monthly membership fee , which gets you a consultation

Its also available as a daily oral tablet